Jiangsu Hansoh Pharmaceutical Group Co., Ltd.

https://www.hspharm.com

Hansoh Pharma (3692:HK) is a leading biopharmaceutical company in China committed to discovering and developing life-changing medicines to help patients conquer serious diseases and disorders, together with its approximately 8,900 employees. Founded in 1995, Hansoh has fully integrated research and development, manufacturing and commercial capabilities, supporting a leadership position in central nervous system (CNS), oncology, anti-infectives and diabetes, among others. With approximately 1,400 professionals across R&D, Hansoh ranks top 2 in innovation among all biotech and pharmaceutical companies in China based on new molecular entity INDs submitted for clinical development since 2011. Hansoh Pharma’s 2018 revenue was approximately US$1.1 billion, representing a year-over-year growth of 25%. *

	Start	1995-01-01 established
	Group	Hansoh Pharmaceutical (Group)
	Industry	pharmaceutical
	Industry 2	drug discovery

	Street	No. 9 Dongjin Road Huaguoshan Avenue
	City	n. a. Lianyungang, Jingsu
		Address record changed: 2023-08-07

Basic data	Employees	G: 5,001 to 10,000 (2019-09-11)
	Currency	USD
	Annual sales	1,100,000,000 (revenue (2018) 2018-12-31)

		* Document for »About Section«: Atomwise, Inc.. (9/11/19). "Press Release: Hansoh Pharma and Atomwise Launch Strategic AI Drug Discovery Collaboration for Multiple Therapeutic Areas". Shanghai & San Francisco, CA.

		Record changed: 2024-08-24